Search research articles
Contact Us
Filters
Showing results (101-110 of 105) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 105 results.
Revista Paulista De Medicina
|
March 1, 1988
[Detection of SSA/Ro antibody in patients with systemic lupus erythematosus, discoid lupus erythematosus and cutaneous photosensitivity. A comparative study]
A M Carazzai, R C Sucena, S I Milano, et al.
Lupus
|
December 1, 1994
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy
M Hojnik, B Gilburd, L Ziporen, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo
|
March 1, 1996
Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R
L M Vieira, E P Sampaio, J A Nery, et al.
Annals of the Rheumatic Diseases
|
April 22, 2014
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
R A Furie, G Leon, M Thomas, et al.
Journal of Clinical Immunology
|
January 1, 1994
Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy
B Gilburd, L Ziporen, D Zharhary, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 105) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 105 results.
Revista Paulista De Medicina
|
March 1, 1988
[Detection of SSA/Ro antibody in patients with systemic lupus erythematosus, discoid lupus erythematosus and cutaneous photosensitivity. A comparative study]
A M Carazzai, R C Sucena, S I Milano, et al.
Lupus
|
December 1, 1994
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy
M Hojnik, B Gilburd, L Ziporen, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo
|
March 1, 1996
Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R
L M Vieira, E P Sampaio, J A Nery, et al.
Annals of the Rheumatic Diseases
|
April 22, 2014
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
R A Furie, G Leon, M Thomas, et al.
Journal of Clinical Immunology
|
January 1, 1994
Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy
B Gilburd, L Ziporen, D Zharhary, et al.
Page
of 11